HCV Case - Understanding Patterns of Hepatitis C Transmission in a Rural Community - Elizabeth Gatley, MBChB, FCP (SA)

Conference on Liver Disease in Africa (COLDA) 2022

HBV Case - When is it NOT Acute Hepatitis B? - Sandy Mosenye, Bsc( Med Science), MBChB, MMed, FCP(SA)

Conference on Liver Disease in Africa (COLDA) 2022

State-of-the-Art Lecture: HBV Cure - Geoffrey Dusheiko, MBBS, FCP(SA) FRCS

Conference on Liver Disease in Africa (COLDA) 2022

Prevalence and Mortality Trends of Hepatitis B and Hepatitis C Infection in Sub-Saharan Africa: A Systematic Analysis for the Global Burden of Disease Study 2020 - Hannah Han

Conference on Liver Disease in Africa (COLDA) 2022

Performance-Based Approach to Accelerate Hepatitis C Elimination in Rwanda - Ephrem Daniel Sheferaw

Conference on Liver Disease in Africa (COLDA) 2022

Hepatitis C Laboratory Data Analysis on Patients Seeking Medical Attention in the Public Health Sector, South Africa, 2017-2021 - Morubula J Manamela

Conference on Liver Disease in Africa (COLDA) 2022

Séroprévalence du virus de l’hépatite D (VHD) chez des patients porteurs chroniques de l’antigène HBs du virus de l’hépatite B (VHB) à Abidjan de janvier 2017 à Aout 2021 (COTE-D’IVOIRE) - Jean-Louis Philippe N'Din

Conference on Liver Disease in Africa (COLDA) 2022

Hepatitis Delta Virus Co/Super-Infection Surveillance among Clinicians: An Often- Neglected Practice in Nigeria - Ijeoma Ifeorah

Conference on Liver Disease in Africa (COLDA) 2022

Hepatitis B Infection Prevalence, Genotype Distribution, and Knowledge of Mother- To-Child Transmission Among Antenatal Care Attendees in Yako, Rural Burkina Faso - Serge Ouoba

Conference on Liver Disease in Africa (COLDA) 2022

Hepatitis B Birth Dose Coverage Remains Dramatically Low in the Gambia and Has Been Disrupted by the COVID-19 Pandemic - Gibril Ndow

Conference on Liver Disease in Africa (COLDA) 2022

Can Integration Reduce Stigma? / Lessons Learned from HIV - Danjuma Adda, MPH, FIMS, Dip-IMS

Conference on Liver Disease in Africa (COLDA) 2022

Integrated Decentralized Guidelines for Care – WHO Guidelines - Philippa Easterbrook, MD, FRCP, MPH, DTM&H

Conference on Liver Disease in Africa (COLDA) 2022

Vertical Transmission, Maternal Care, and Family Care - Manal El-Sayed, MD, PhD

Conference on Liver Disease in Africa (COLDA) 2022

Blood Safety & Surveillance - Yuyun S. Maryuningsih, MD, PhD

Conference on Liver Disease in Africa (COLDA) 2022

From Pandemic Response to Pandemic Recovery - Opportunities for Viral Hepatitis Elimination - John Ward, MD

Conference on Liver Disease in Africa (COLDA) 2022

Call for Action - “Call for Action - “We Need Testing and Treatment - NOW” - Bisi Bright, B.Pharm(Hons), MPH, FPCPharm, FPSN, C.Psych

Conference on Liver Disease in Africa (COLDA) 2022

Call for Action - “We Need Solutions” - Agnes Binagwaho, MD, M(Ped), PhD

Conference on Liver Disease in Africa (COLDA) 2022

Call for Action - “We Need (HQ) Data - To Plan Services” - Olufunmilayo Lesi, MD, MBA, FMCP

Conference on Liver Disease in Africa (COLDA) 2022

Call for Action - “We Need to Address the Challenges - Now” - The South African Experience - Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD

Conference on Liver Disease in Africa (COLDA) 2022

International Viral Hepatitis Elimination Meeting (IVHEM) 2022 - Promo Video

International Viral Hepatitis Elimination Meeting (IVHEM) 2022

MHPLTO Glasgow_Georg Behrens

Managing HIV Patients with Limited Treatment Options 2022

Clinical Data from the GP120 Inhibitor Temsavir and its Relevance to Immune Reconstitution and HIV Associated Inflammation - Georg Behrens, MD, PhD

HIV Glasgow 2022 Symposium - The Devil Wears GP120

Immune Dysregulation – a Remaining Challenge in HIV Medicine - John Thornhill, PhD, MB BCh, BMed Sci

HIV Glasgow 2022 Symposium - The Devil Wears GP120

Cirrhosis Management in Resource Constraint Environments - Mark Sonderup, B Pharm, MBChB, FCP(SA), Mmed

Conference on Liver Disease in Africa (COLDA) 2022